共 67 条
- [1] Chesnutt CH(2008)Salmon calcitonin: a review of current and future therapeutic indications Osteoporosis International. 19 479-491
- [2] Azria M(1992)Three-year calcitonin combination therapy for postmenopausal osteoporosis with crush fractures of the spine Calcified Tissue International 50 7-10
- [3] Silverman S(1987)Synthetic human calcitonin in refractory Paget’s disease of bone Archives of Internal Medicine 147 1305-1308
- [4] Szucs J(1992)Calcitonin in painful diabetic neuropathy Lancet 339 746-747
- [5] Horvath C(1997)Pain relief from nasal salmon calcitonin in osteoporotic vertebral crush fractures. A double-blind, placebo-controlled clinical study Acta Orthopaedica Scandinavica 275 112-114
- [6] Kollin E(2009)Nasal delivery of high molecular weight drugs Molecules 14 3754-3779
- [7] Altman RD(2016)A randomized, double-blind, multicenter, placebo-controlled study to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of osteoporosis in postmenopausal women taking calcium and vitamin D Bone 91 122-129
- [8] Collins-Yudiskas B(2016)Does salmon calcitonin cause cancer? A review and meta-analysis Osteoporosis International. 27 13-19
- [9] Quatraro A(2014)Calcitonin nasal spray and increased cancer risk: A population-based nested case-control study Journal of Clinical Endocrinology and Metabolism 99 4259-4264
- [10] Minei A(2004)The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis New England Journal of Medicine 350 459-468